iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsule 5 mg, 10 mg, 15 mg and 25 mg from the United States Food and Drug Administration (US FDA). Ciplas Lenalidomide Capsules are AB-rated therapeutic equivalent generic version of Bristol Myers Squibbs (Celgene) Revlimid? (Lenalidomide) Capsules. Lenalidomide is an immunomodulatory prescription drug which is indicated for several […]

image

On 26 September 2022

image

Central Bank of India has entered into a strategic co-lending partnership with Home First Finance Company (HFFC) India to offer offer home loans to borrowers at competitive rate.

image

ICICI Lombard General Insurance Company has allotted 6400 equity shares on 06 September 2022 under ESOP. Powered by Capital Market – Live News

image

On 30 September 2022

image

The IT major on Wednesday announced a five-year agreement with Spirit AeroSystems, Inc., one of the worlds largest manufacturers of aerostructures for commercial airplanes, defense platforms, and business/regional jets.

image

The domestic equity benchmarks ended with limited losses after a volatile session on Wednesday. After opening slightly above 17,500 mark, the Nifty managed to pare most losses as it closed above the 17,600 level. While autos, banks and financials witnessed significant selling, pharma, healthcare and consumer durable stocks managed to end with decent gains. As per provisional closing data, the barometer index, the S&P BSE […]

image

On 26 September 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.